TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-139.73M | -21.9% |
| 2024 | $-114.65M | -77.7% |
| 2023 | $-64.50M | +8.8% |
| 2022 | $-70.73M | -20.7% |
| 2021 | $-58.62M | -707.3% |
| 2020 | $-7.26M | +47.3% |
| 2019 | $-13.77M | - |